Le Lézard
Classified in: Health
Subjects: NPT, CHI, DIS, FVT, DEI

KENTUCKY SPECIAL PARENT INVOLVEMENT NETWORK OFFERING FREE 'BRIDGE THE GAP IN SPECIAL EDUCATION' VIRTUAL SEMINARS


Grant from WellCare helps fund training for parents of children with disabilities

LOUISVILLE, Ky. , Dec. 19, 2023 /PRNewswire/ -- The Kentucky Special Parent Involvement Network (KY-SPIN), a statewide non-profit organization that links families and individuals with disabilities to valuable resources that will enable them to live productive and fulfilling lives, is offering two free seminars to provide in-depth training for professionals and parents of children with disabilities.

The seminars will be presented via Zoom, on Jan. 11 and Jan. 27, 2024, from 9am-5pm (EST).

The seminars are part of a statewide series, sponsored in part by WellCare of Kentucky, a whole-owned subsidiary of Centene Corporation, (NYSE: CNC).

"This seminar provides a place for parents of children with disabilities to come and receive trainings on issues they are facing and the tools to aid in their child's development," said WellCare's Plan President, Corey Ewing. "WellCare is pleased to be able to sponsor these trainings that support families in Kentucky."

Registrants can choose to attend all sessions or individual sessions.

KY-SPIN's Bridging the Gap in Special Education Training agenda:

9-10am (EST) - Building Partnerships
10-10:30am - Overview of Section 504, Americans with Disabilities Act (ADA) & Individuals with Disabilities Education Improvement Act (IDEA) 2004
10:30am-12pm - Overview of Special Education Process (IDEA Part B: ages 3-21) ? Individualized Education Program (IEP)
12-12:30pm -Lunch break
12:30-2:30pm - Individualized Education Program (IEP) Continued
2:30-3pm - IDEA Procedural Safeguards & Dispute Resolution
3-4pm 504 - Plan Overview
4-5pm - Individual Health Plan (IHP) 

To register, visit kyspin.com or call 800-525-7746.

About KY-SPIN
Kentucky Special Parent Involvement Network (KY-SPIN) is a statewide non-profit organization. The mission of KY-SPIN, Inc. is to link families and individuals with disabilities to valuable resources that will enable them to live productive, fulfilling lives. For more information, please visit www.kyspin.com.

About WellCare Kentucky
WellCare of Kentucky provides government-sponsored managed care services to families, children, seniors, and individuals with complex needs primarily through Medicaid, Medicare Advantage, and Medicare Prescription Drug Plans across the state. WellCare is a wholly owned subsidiary of Centene Corporation, a leading healthcare enterprise committed to helping people live healthier lives. For more information, please visit wellcare.com/kentucky.

 

SOURCE WellCare of Kentucky


These press releases may also interest you

at 22:34
Cynata Therapeutics Limited , a clinical-stage biotechnology company specialising in cell therapeutics, has successfully completed its Phase 1 clinical trial of CYP-006TK in diabetic foot ulcers (DFU). Key Highlights The trial met its primary...

at 21:44
BioArctic AB's (publ) partner Eisai today announced that the Federal Commission for the Protection Against Sanitary Risk (COFEPRIS) in Mexico has approved Leqembi (lecanemab) for the treatment of early Alzheimer's disease (AD)1.   Leqembi...

at 20:20
dBio has joined the American Heart Association Center for Health Technology & Innovation (the Center) Innovators' Network, an initiative focused on building and fostering health technology relationships to develop innovative and scalable...

at 20:05
The Asian Entrepreneurship Award (AEA) Steering Committee is pleased to announce that AEA2024, the 13th annual innovation award event for fast-growing Asian startups, was held on November 20th and 21st. Taking place in-person for the first time in...

at 18:40
Roswell Park CEO Candace S. Johnson, PhD, introduces center's first Physician in Chief, leaders in strategic areas Michael Wong, MD, PhD, FRPC, joins Roswell Park from MD Anderson...

at 18:31
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. announced today that the Federal Commission for the Protection Against Sanitary Risk (COFEPRIS) in Mexico has approved humanized anti-soluble aggregated amyloid-beta...



News published on and distributed by: